Literature DB >> 3106495

Cell matrix adhesion-related proteins VLA-1 and VLA-2: regulation of expression on T cells.

M E Hemler, J G Jacobson.   

Abstract

The mitogens phytohemagglutinin (PHA) and concanavalin A inhibited the appearance of the very late activation antigen (VLA)-1, but did not inhibit VLA-2 expression on cultured activated T cells. In contrast to diminished VLA-1 expression, mitogen treatment caused increased cell surface expression of other activation antigens such as T10, HLA-DR, interleukin 2 (IL 2) receptor, and 4F2, and greater cell proliferation. Conversely, when T cells were not repetitively restimulated with mitogen, these less proliferative "postactivated" T cells had elevated VLA-1 expression. The diminished expression of VLA-1 caused by PHA was reversible since subsequent removal of mitogen was associated with increased VLA-1, paralleled by a decrease in interleukin 2 receptor levels. In addition to preventing or delaying the initial appearance of VLA-1, PHA stimulation also was somewhat effective in causing the disappearance of VLA-1 already present, especially on recently established cultures. However, cultures that had either never seen PHA, not seen PHA for several weeks, or been stimulated regularly with PHA, but were several months old, did not lose VLA-1 in response to PHA stimulation, suggesting that a state of insensitivity to PHA effects could be attained. Unlike PHA-stimulated T cells, T cells repetitively restimulated with alloantigen or the monoclonal antibody T3 did not show a marked absence of VLA-1 but rather showed an increased level of VLA-2 relative to VLA-1. Taken together, results of stimulation by either mitogen, alloantigen, or anti-T3 monoclonal antibody support the conclusion that T cell stimulation in general can cause a decreased VLA-1:VLA-2 ratio, whether by decreased VLA-1 or increased VLA-2. These shifts in VLA-1:VLA-2 ratios are probably not simply the result of shifts in the relative proportions of different subpopulations, because similar growth-related changes in this ratio were observed on the T cell line ANITA, which is a homogeneous population of cells. Because both VLA-1 and VLA-2 are differentially regulated on cultured, long term activated T cells depending on stage of activation and growth conditions, and are members of a family of at least five heterodimers that includes cell matrix adhesion molecules, we suggest that these studies will provide clues to novel aspects of T cell growth regulation, perhaps relating to T cell-matrix adhesion.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3106495

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  14 in total

1.  Expression and role of integrins in adhesion of human colonic carcinoma cells to extracellular matrix components.

Authors:  C Schreiner; J Bauer; M Margolis; R L Juliano
Journal:  Clin Exp Metastasis       Date:  1991 Mar-Apr       Impact factor: 5.150

2.  Widespread histologic distribution of the alpha 2 beta 1 integrin cell-surface collagen receptor.

Authors:  M M Zutter; S A Santoro
Journal:  Am J Pathol       Date:  1990-07       Impact factor: 4.307

3.  Adhesion molecule mapping in normal human skin.

Authors:  U Konter; I Kellner; E Klein; R Kaufmann; V Mielke; W Sterry
Journal:  Arch Dermatol Res       Date:  1989       Impact factor: 3.017

4.  Decreased expression of integrin adhesive protein receptors in adenocarcinoma of the breast.

Authors:  M M Zutter; G Mazoujian; S A Santoro
Journal:  Am J Pathol       Date:  1990-10       Impact factor: 4.307

5.  High expression of adhesion molecules/activation markers with little interleukin-2, interferon gamma, and tumor necrosis factor beta gene activation in fresh tumor-infiltrating lymphocytes from lung adenocarcinoma.

Authors:  E Roussel; M C Gingras; E A Grimm; J A Roth
Journal:  Cancer Immunol Immunother       Date:  1995-07       Impact factor: 6.968

6.  Increased expression of laminin/collagen receptor (VLA-1) on epithelium of inflamed human intestine.

Authors:  T T MacDonald; M A Horton; M Y Choy; P I Richman
Journal:  J Clin Pathol       Date:  1990-04       Impact factor: 3.411

7.  Adhesion molecules in normal human conjunctiva. An immunohistological study using monoclonal antibodies.

Authors:  M Vorkauf; G Duncker; B Nölle; W Sterry
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1993-06       Impact factor: 3.117

8.  Interaction of disease-related antigen-reactive T-cell lines from multiple sclerosis patients with type IV collagen: role of integrin VLA-1 and effects of irradiation.

Authors:  Ilan Bank; Anat Achiron; Gad Levie; Alexander Koltakov; Mathilda Mandel
Journal:  J Clin Immunol       Date:  2002-05       Impact factor: 8.317

9.  Expression and functions of very late antigen 1 in inflammatory joint diseases.

Authors:  I Bank; D Roth; M Book; A Guterman; I Shnirrer; R Block; M Ehrenfeld; P Langevitz; H Brenner; M Pras
Journal:  J Clin Immunol       Date:  1991-01       Impact factor: 8.317

10.  Differential expression of beta 1 integrins in nonneoplastic smooth and striated muscle cells and in tumors derived from these cells.

Authors:  G Mechtersheimer; T Barth; A Quentmeier; P Möller
Journal:  Am J Pathol       Date:  1994-06       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.